Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the NYSE in New York (Reuters) - Johnson & Johnson ...

Johnson & Johnson’s top executive should be forced to testify about claims that the company illegally marketed the antipsychotic drug Risperdal, which allegedly caused boys to grow breasts, lawyers ...

Johnson & Johnson promoted illegal marketing of its antipsychotic drug Risperdal by paying physicians to give favorable speeches, subsidizing golf trips and even having sales staff “butter up doctors” ...

A Philadelphia jury has ordered medical company Johnson & Johnson to pay $8 billion in punitive damages in the case of a man who said he developed breasts after taking the company's anti-psychotic ...

Johnson & Johnson has been battling legal issues on several fronts—ranging from opioids to talc to medical devices—and Wednesday, its fight got a little tougher. Pennsylvania’s Supreme Court ruled ...

WASHINGTON - Johnson & Johnson has tentatively agreed to settle a single misdemeanor criminal charge related to a multiyear government investigation into the marketing of its psychiatric drug ...

A jury in Philadelphia said Tuesday that Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that the New Brunswick-based company failed to ...

Now that Johnson & Johnson has agreed to pay $158 million to settle a lawsuit in which the Texas Attorney General charged the drugmaker with a whopper of a scheme to illegally promote its Risperdal ...

The FDA told Johnson & Johnson (JNJ) in 1997 that its request to market the antipsychotic drug Risperdal for children was "without any justification." In the following years, J&J's army of ...

Johnson & Johnson, still reeling from settling two Ohio opioid-related lawsuits for more than $20 million, was slapped with an $8 billion judgment on Tuesday over its antipsychotic drug Risperdal. A ...

In a blow to Johnson & Johnson, the company was ordered last Friday to pay $70 million to a male Tennessee teenager who claimed its Risperdal antipsychotic pill caused him to grow enlarged breasts.

Johnson & Johnson's schizophrenia drug Risperdal at Skenderian Apothecary in Cambridge, Massachusetts, on Jan. 23, 2007. Photo: JB Reed/Bloomberg News. The Pennsylvania Supreme Court has ruled that ...